Ja Kyung Yoon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ja Kyung Yoon has a total of 81 co-authors. Here are the top co-authors by number of shared publications:
- Sunyoung Lee
Department of Radiology and Research Institute of Radiological Science, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
7 shared publications - Jin-Young Choi
Department of Radiology and Research Institute of Radiological Science, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea
6 shared publications - Jaeseung Shin
Department of Radiology, Samsung Medical Center, 81 Irwon-ro, Irwon-dong - Gangnam-gu, Seoul, 06351, Republic of Korea, 82 10-8714-7650
4 shared publications - Mi-Suk Park
Department of Radiology, Research Institute of Radiological Science, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea
4 shared publications - Seung-Seob Kim
Department of Radiology and Research Institute of Radiological Science, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
4 shared publications - Yong Eun Chung
Department of Radiology, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea.
4 shared publications
Latest Publications
- Open Access
Strategy to Improve Diagnostic Performance of Hepatic Steatosis Grading Using Ultrasound: Combination of Qualitative and Quantitative Approaches
Background and Objectives: To propose an integrated qualitative and quantitative US strategy for improving the diagnostic accuracy of hepatic steatosis (HS) grading. Materials and Methods: We retrospectively identified patients at a tertiary hospital who underwent B-mode US examination, attenuation imaging (ATI), hepatorenal index (HRI), and liver biopsy on the same day between 2023 and 2024. B-mode liver US images were independently reviewed by three radiologists with varying levels of experience. Each radiologist qualitatively assessed the degree of HS using a three-tier grading system: (1) no HS, (2) mild HS, and (3) moderate/severe HS. Median attenuation coefficient (AC) and HRI values were recorded. Liver biopsy pathology reports were used as the reference standard. We evaluated four strategies integrating qualitative assessment with ATI or HRI and compared their diagnostic performance. Results: Based on B-mode US, accuracies for detecting HS by the three radiologists were 87.0%, 87.0%, and 86.0%, respectively; for moderate/severe HS, the values were 79.0%, 76.0%, and 71.0%. ATI and HRI alone yielded diagnostic accuracies of 83.0% and 81.0%, respectively, for any HS and 67.0% and 53.0%, respectively, for moderate/severe HS. The highest accuracy was achieved using a strategy that retained the qualitative grade for one-grade discrepancies and assigning the intermediate grade only for two-grade discrepancies between the AC-based grade and the qualitative grade (93.0%, 87.0%, and 90.0% for any HS; 80.0%, 76.0%, and 74.0% for moderate/severe HS). Conclusions: The proposed integration strategy, which retained the qualitative grade for one-grade discrepancies and assigned the intermediate grade only for two-grade discrepancies, improved or maintained diagnostic performance, regardless of the radiologist’s level of experience.
Open AccessStrategy to Improve Diagnostic Performance of Hepatic Steatosis Grading Using Ultrasound: Combination of Qualitative and Quantitative Approaches
Background and Objectives: To propose an integrated qualitative and quantitative US strategy for improving the diagnostic accuracy of hepatic steatosis (HS) grading. Materials and Methods: We retrospectively identified patients at a tertiary hospital who underwent B-mode US examination, attenuation imaging (ATI), hepatorenal index (HRI), and liver biopsy on the same day between 2023 and 2024. B-mode liver US images were independently reviewed by three radiologists with varying levels of experience. Each radiologist qualitatively assessed the degree of HS using a three-tier grading system: (1) no HS, (2) mild HS, and (3) moderate/severe HS. Median attenuation coefficient (AC) and HRI values were recorded. Liver biopsy pathology reports were used as the reference standard. We evaluated four strategies integrating qualitative assessment with ATI or HRI and compared their diagnostic performance. Results: Based on B-mode US, accuracies for detecting HS by the three radiologists were 87.0%, 87.0%, and 86.0%, respectively; for moderate/severe HS, the values were 79.0%, 76.0%, and 71.0%. ATI and HRI alone yielded diagnostic accuracies of 83.0% and 81.0%, respectively, for any HS and 67.0% and 53.0%, respectively, for moderate/severe HS. The highest accuracy was achieved using a strategy that retained the qualitative grade for one-grade discrepancies and assigning the intermediate grade only for two-grade discrepancies between the AC-based grade and the qualitative grade (93.0%, 87.0%, and 90.0% for any HS; 80.0%, 76.0%, and 74.0% for moderate/severe HS). Conclusions: The proposed integration strategy, which retained the qualitative grade for one-grade discrepancies and assigned the intermediate grade only for two-grade discrepancies, improved or maintained diagnostic performance, regardless of the radiologist’s level of experience.
- Open Access
- 15 July 2026
- Published by The Korean Society of Abdominal Radiology in Korean Journal of Abdominal Radiology
- Vol. 9 (1) , 14-31
Arterial-Phase Enhancement Patterns of Hepatocellular Carcinoma: From Pathologic Background to Prognostication and Treatment Response
Arterial-phase hyperenhancement (APHE), which reflects the hemodynamic shift toward an unpaired arterial supply during hepatocarcinogenesis, is one of the most important imaging features for noninvasive diagnosis of hepatocellular carcinoma (HCC). Although the classic non-rim APHE remains the cornerstone of diagnosis, various enhancement patterns have emerged as critical biomarkers for tumor biology and prognosis. This review provides a comprehensive overview of APHE, tracing its historical development alongside technical advancements in angiography, computed tomography, and magnetic resonance imaging, and explores the pathological and genetic backgrounds of APHE. We categorized distinct enhancement phenotypes, including rim APHE, Kawamura classification, arterial-phase hypoenhancing component, intratumoral artery, and arterial-phase peritumoral enhancement. These patterns serve as imaging surrogates for aggressive clinicopathological traits, such as microvascular invasion, the macrotrabecular-massive subtype, the vessels encapsulating tumor cluster pattern, and TP53 mutation. Furthermore, we discuss how these arterial enhancement patterns guide treatment strategies and predict outcomes of surgical resection, locoregional therapies, and contemporary systemic treatments. Understanding the relationship between diverse enhancement patterns and HCC biology is vital for optimizing therapeutic decision-making.
- 15 July 2026
- Published by The Korean Society of Abdominal Radiology in Korean Journal of Abdominal Radiology
- Vol. 9 (1) , 14-31
Open AccessArterial-Phase Enhancement Patterns of Hepatocellular Carcinoma: From Pathologic Background to Prognostication and Treatment Response
Arterial-phase hyperenhancement (APHE), which reflects the hemodynamic shift toward an unpaired arterial supply during hepatocarcinogenesis, is one of the most important imaging features for noninvasive diagnosis of hepatocellular carcinoma (HCC). Although the classic non-rim APHE remains the cornerstone of diagnosis, various enhancement patterns have emerged as critical biomarkers for tumor biology and prognosis. This review provides a comprehensive overview of APHE, tracing its historical development alongside technical advancements in angiography, computed tomography, and magnetic resonance imaging, and explores the pathological and genetic backgrounds of APHE. We categorized distinct enhancement phenotypes, including rim APHE, Kawamura classification, arterial-phase hypoenhancing component, intratumoral artery, and arterial-phase peritumoral enhancement. These patterns serve as imaging surrogates for aggressive clinicopathological traits, such as microvascular invasion, the macrotrabecular-massive subtype, the vessels encapsulating tumor cluster pattern, and TP53 mutation. Furthermore, we discuss how these arterial enhancement patterns guide treatment strategies and predict outcomes of surgical resection, locoregional therapies, and contemporary systemic treatments. Understanding the relationship between diverse enhancement patterns and HCC biology is vital for optimizing therapeutic decision-making.
- Open Access
- 1 January 2026
- Published by XMLink in Korean Journal of Radiology
- Vol. 27 (9) , 868
Beyond Diagnosis: Magnetic Resonance Imaging-Based Imaging Biomarkers for Tumor Biology, Prognosis, and Clinical Decision-Making in Hepatocellular Carcinoma
Yoon JK, et al. Korean J Radiol. 2026 ;27:e75. https://doi.org/10.3348/kjr.2026.0320
- 1 January 2026
- Published by XMLink in Korean Journal of Radiology
- Vol. 27 (9) , 868
Open AccessBeyond Diagnosis: Magnetic Resonance Imaging-Based Imaging Biomarkers for Tumor Biology, Prognosis, and Clinical Decision-Making in Hepatocellular Carcinoma
Yoon JK, et al. Korean J Radiol. 2026 ;27:e75. https://doi.org/10.3348/kjr.2026.0320
- 1 March 2025
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 314 (3) , e240450
US Liver Imaging Reporting and Data System Version 2017: A Systematic Review and Meta-Analysis
Among 39 166 US examinations performed for hepatocellular carcinoma (HCC) surveillance, 90% were negative and 92% had adequate quality based on visualization scores; 26% of US-3 (positive) examinations had malignancies, primarily HCC.
- 1 March 2025
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 314 (3) , e240450
US Liver Imaging Reporting and Data System Version 2017: A Systematic Review and Meta-Analysis
Among 39 166 US examinations performed for hepatocellular carcinoma (HCC) surveillance, 90% were negative and 92% had adequate quality based on visualization scores; 26% of US-3 (positive) examinations had malignancies, primarily HCC.
- Open Access
- 1 January 2025
- Published by XMLink in Journal of the Korean Society of Radiology
- Vol. 86 (3) , 364-380
MRI Imaging Biomarkers for Prognostication of Hepatocellular Carcinoma
윤자경, et al. J Korean Soc Radiol. 2025 May;86(3):364-380. https://doi.org/10.3348/jksr.2025.0029
- 1 January 2025
- Published by XMLink in Journal of the Korean Society of Radiology
- Vol. 86 (3) , 364-380
Open AccessMRI Imaging Biomarkers for Prognostication of Hepatocellular Carcinoma
윤자경, et al. J Korean Soc Radiol. 2025 May;86(3):364-380. https://doi.org/10.3348/jksr.2025.0029
- Open Access
- 15 June 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-15
Chip collection of hepatocellular carcinoma based on O2 heterogeneity from patient tissue
Hepatocellular carcinoma frequently recurs after surgery, necessitating personalized clinical approaches based on tumor avatar models. However, location-dependent oxygen concentrations resulting from the dual hepatic vascular supply drive the inherent heterogeneity of the tumor microenvironment, which presents challenges in developing an avatar model. In this study, tissue samples from 12 patients with hepatocellular carcinoma are cultured directly on a chip and separated based on preference of oxygen concentration. Establishing a dual gradient system with drug perfusion perpendicular to the oxygen gradient enables the simultaneous separation of cells and evaluation of drug responsiveness. The results are further cross-validated by implanting the chips into mice at various oxygen levels using a patient-derived xenograft model. Hepatocellular carcinoma cells exposed to hypoxia exhibit invasive and recurrent characteristics that mirror clinical outcomes. This chip provides valuable insights into treatment prognosis by identifying the dominant hepatocellular carcinoma type in each patient, potentially guiding personalized therapeutic interventions.
- 15 June 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-15
Open AccessChip collection of hepatocellular carcinoma based on O2 heterogeneity from patient tissue
Hepatocellular carcinoma frequently recurs after surgery, necessitating personalized clinical approaches based on tumor avatar models. However, location-dependent oxygen concentrations resulting from the dual hepatic vascular supply drive the inherent heterogeneity of the tumor microenvironment, which presents challenges in developing an avatar model. In this study, tissue samples from 12 patients with hepatocellular carcinoma are cultured directly on a chip and separated based on preference of oxygen concentration. Establishing a dual gradient system with drug perfusion perpendicular to the oxygen gradient enables the simultaneous separation of cells and evaluation of drug responsiveness. The results are further cross-validated by implanting the chips into mice at various oxygen levels using a patient-derived xenograft model. Hepatocellular carcinoma cells exposed to hypoxia exhibit invasive and recurrent characteristics that mirror clinical outcomes. This chip provides valuable insights into treatment prognosis by identifying the dominant hepatocellular carcinoma type in each patient, potentially guiding personalized therapeutic interventions.
- Open Access
- 1 January 2024
- Published by XMLink in Korean Journal of Radiology
- Vol. 25 (10) , 902-912
Ultrasound-Guided Percutaneous Biopsy With Needle Track Plugging in Patients With Focal Liver Lesions on an Outpatient Basis: A Randomized Controlled Trial
Yoon JK, et al. Korean J Radiol. 2024 Oct;25(10):902-912. https://doi.org/10.3348/kjr.2024.0536
- 1 January 2024
- Published by XMLink in Korean Journal of Radiology
- Vol. 25 (10) , 902-912
Open AccessUltrasound-Guided Percutaneous Biopsy With Needle Track Plugging in Patients With Focal Liver Lesions on an Outpatient Basis: A Randomized Controlled Trial
Yoon JK, et al. Korean J Radiol. 2024 Oct;25(10):902-912. https://doi.org/10.3348/kjr.2024.0536
- Open Access
- 1 January 2024
- Published by XMLink in Yonsei Medical Journal
- Vol. 65 (7) , 371-379
Comparison between Nivolumab and Regorafenib as Second-line Systemic Therapies after Sorafenib Failure in Patients with Hepatocellular Carcinoma
Lee HJ, et al. Yonsei Med J. 2024 Apr;65:e18. https://doi.org/10.3349/ymj.2023.0263
- 1 January 2024
- Published by XMLink in Yonsei Medical Journal
- Vol. 65 (7) , 371-379
Open AccessComparison between Nivolumab and Regorafenib as Second-line Systemic Therapies after Sorafenib Failure in Patients with Hepatocellular Carcinoma
Lee HJ, et al. Yonsei Med J. 2024 Apr;65:e18. https://doi.org/10.3349/ymj.2023.0263
- Open Access
- 1 January 2024
- Published by XMLink in Investigative Magnetic Resonance Imaging
- Vol. 28 (1) , 8-17
Image Quality and Focal Lesion Detectability Analysis of Multiband Variable-Rate Selective Excitation Diffusion-Weighted Imaging of the Liver Using 3.0-T MRI
Yoon JK, et al. Investig Magn Reson Imaging. 2024 Mar;28(1):8-17. https://doi.org/10.13104/imri.2023.0027
- 1 January 2024
- Published by XMLink in Investigative Magnetic Resonance Imaging
- Vol. 28 (1) , 8-17
Open AccessImage Quality and Focal Lesion Detectability Analysis of Multiband Variable-Rate Selective Excitation Diffusion-Weighted Imaging of the Liver Using 3.0-T MRI
Yoon JK, et al. Investig Magn Reson Imaging. 2024 Mar;28(1):8-17. https://doi.org/10.13104/imri.2023.0027
- Open Access
- 1 January 2024
- Published by XMLink in Investigative Magnetic Resonance Imaging
- Vol. 28 (1) , 27-35
Comparison of Volumetric Measurement Method With Region of Interest Drawing Method for Liver Fat Quantification
Lee H, et al. Investig Magn Reson Imaging. 2024 Mar;28(1):27-35. https://doi.org/10.13104/imri.2023.0020
- 1 January 2024
- Published by XMLink in Investigative Magnetic Resonance Imaging
- Vol. 28 (1) , 27-35
Open AccessComparison of Volumetric Measurement Method With Region of Interest Drawing Method for Liver Fat Quantification
Lee H, et al. Investig Magn Reson Imaging. 2024 Mar;28(1):27-35. https://doi.org/10.13104/imri.2023.0020